Dual induction of TREM2 and tolerance-related transcript, Tmem176b, in amyloid transgenic mice: Implications for vaccine-based therapies for Alzheimer's disease

ASN Neuro

Volumn 2, Issue 3, 2010, Pages 157-170

  Melchior, Benoit ^b   Garcia, Angie E ^b   Hsiung, Bor Kai ^b   Lo, Katherine M ^b   Doose, Jonathan M ^b   Cameron Thrash, J ^b   Stalder, Anna K ^c   Staufenbiel, Matthias ^d   Neumann, Harald ^e   Carson, Monica J ^a  

^a OREGON STATE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d NOVARTIS PHARMA AG   (Switzerland)

^e UNIVERSITY OF BONN   (Germany)

Author keywords

Antigen presentation; Autoimmunity; Clast1; Neuroinflammation; Torid

Indexed keywords

EID: 77956238665     PISSN: None     EISSN: 17590914     Source Type: Journal    
DOI: 10.1042/AN20100010     Document Type: Article

References (71)

1. Afagh A, Cummings BJ, Cribbs DH, Cotman CW, Tenner AJ (1996) Localization and cell association of C1q in Alzheimer's disease brain. Exp Neurol 138:22-32.
2. Bianchin MT, Capella HM, Chaves DL, Steindel M, Grisard EC, Ganev GG, da Silva Júnior JP, Neto Evaldo S, Poffo MA, Walz R, Carlotti Ju ́nior CG, Sakamoto AC (2004) Nasu-Hakola disease (polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy-PLOSL): a dementia associated with bone cystic lesions. From clinical to genetic and molecular aspects. Cell Mol Neurobiol 24:1-24.
3. Bouchon A, Hernández-Munain C, Cella M, Colonna M (2001) A DAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cells. J Exp Med 194:1111-1122.
4. Brynskikh A, Warren T, Zhu J, Kipnis J (2008) Adaptive immunity affects learning behavior in mice. Brain Behav Immun 22:861-869.
5. Butovsky O, Bukshpan S, Kunis G, Jung S, Schwartz M (2007) Microglia can be induced by IFN-c or IL-4 to express neural or dendritic-like markers. Mol Cell Neurosci 35:490-500.
6. Byram SC, Carson MJ, DeBoy CA, Serpe CJ, Sanders VM, Jones KJ (2004). CD4-positive T cell-mediated neuroprotection requires dual compartment antigen presentation. J Neurosci 24:4333-4339.
7. Cameron B, Landreth GE (2010) Inflammation, microglia, and Alzheimer's disease. Neurobiol Dis 37:503-509.
8. Cardona AE, Pioro EP, Sasse ME, Kostenko V, Cardona SM, Dijkstra IM, Huang D, Kidd G, Dombrowski S, Dutta R, Lee JC, Cook DN, Jung S, Lira SA, Littman DR, Ransohoff RM (2006) Control of microglial neurotoxicity by the fractalkine receptor. Nat Neurosci 9:917-924.
9. Carson MJ, Behringer RR, Brinster RL, McMorris FA (1993) Insulin-like growth factor I increases brain growth and central nervous system myelination in transgenic mice. Neuron 10:729-740.
10. Carson MJ, Reilly DR, Sutcliffe JG, Lo D (1998) Mature microglia resemble immature antigen-presenting cells. Glia 22:72-85.
11. Carson MJ, Sutcliffe JG, Campbell IL (1999) Microglia stimulate naive T-cell differentiation without stimulating T-cell proliferation. J Neurosci Res 55:127-134.
12. Carson MJ, Doose JM, Melchior B, Schmid CD, Ploix CC (2006) CNS immune privilege: hiding in plain sight. Immunol Rev 213:48-65.
13. Carson MJ, Bilousova TV, Puntambekar SS, Melchior B, Doose JM, Ethell IM (2007) A rose by any other name? The potential consequences of microglial heterogeneity during CNS health and disease. Neurotherapeutics 4:571- 579.
14. Chouery E, Delague V, Bergougnoux A, Koussa S, Serre JL, Mégarbané A (2008) Mutations in TREM2 lead to pure early-onset dementia without bone cysts. Hum Mutat 29:E194-E204.
15. Clark AK, Staniland AA, Marchand F, Kaan TKY, McMahon SB, Malcangio M (2010) P2X7-dependent release of interleukin-1b and nociception in the spinal cord following lipopolysaccharide. J Neurosci 30:573-582.
16. Davis DS, Carson MJ (2009) When the tail can't wag the dog: the implications of CNS-intrinsic initiation of neuroinflammation. ASN NEURO.1(2):art: e00008.doi:10.1042/AN20090024
17. Derecki NC, Privman E, Kipnis J (2010) Rett syndrome and other autism spectrum disorders: brain diseases of immune malfunction? Mol Psych 15:355-363.
18. El Khoury J, Toft M, Hickman SE, Means TK, Terada K, Geula C, Luster AD (2007) Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease. Nat Med 13:432-438.
19. Fan R, Tenner AJ (2004) Complement C1q expression induced by Ab in rat hippocampal organotypic slice cultures. Exp Neurol 185:241-253.
20. Färber K, Cheung G, Mitchell D, Wallis R, Weihe E, Schwaeble W, Kettenmann H (2009) C1q, the recognition subcomponent of the classical pathway of complement, drives microglial activation. J Neurosci Res 87:644-652.
21. Fisher Y, Nemirovsky A, Baron R, Monsonego A (2010) T cells specifically targeted to amyloid plaques enhance plaque clearance in a mouse model of Alzheimer's disease. PLoS One5(5): e10830:doi:10.1371/journal. pone.0010830.
22. Frank S, Burbach GJ, Bonin M, Walter M, Streit W, Bechmann I, Deller T (2008) TREM2 is upregulated in amyloid plaque-associated microglia in aged APP23 transgenic mice. Glia 56:1438-1447.
23. Fuhrmann M, Bittner T, Jung CKE, Burgold S, Page RM, Mitteregger G, Haass C, LaFerla FM, Kretzschmar H, Herms J (2010) Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer's disease. Nat Neurosci 13:411-413.
24. Gaikwad S, Larionov S, Wang Y, Dannenberg H, Matozaki T, Monsonego A, Thal DR, Neumann H (2009) Signal regulatory protein-b1: a microglial modulator of phagocytosis in Alzheimer's disease. Am J Pathol 175:2528-2539.
25. Graeber MB, Streit WJ (2010) Microglia: biology and pathology. Acta Neuropathol 119:89-105.
26. Grathwohl SA, Kälin RE, Bolmont T, Prokop S, Winkelmann G, Kaeser SA, Odenthal J, Radde R, Eldh T, Gandy S, Aguzzi A, Staufenbiel M, Mathews PM, Wolburg H, Heppner FL, Jucker M (2009) Formation and maintenance of Alzheimer's disease beta-amyloid plaques in the absence of microglia. Nat Neurosci 12:1361-1363.
27. Greter M, Heppner FL, Lemos MP, Odermatt BM, Goebels N, Laufer T, Noelle RJ, Becher B (2005) Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. Nat Med 11:328-334.
28. Grommes C, Lee CYD, Wilkinson BL, Jiang Q, Koenigsknecht-Talboo JL, Varnum B, Landreth GE (2008) Regulation of microglial phagocytosis and inflammatory gene expression by Gas6 acting on the Axl/Mer family of tyrosine kinases. J Neuroimmune Pharmacol 3:130-140.
29. Hamerman JA, Jarjoura JR, Humphrey MB, Nakamura MC, Seaman WE, Lanier LL (2006) Cutting edge: inhibition of TLR and FcR responses in macrophages by triggering receptor expressed on myeloid cells (TREM)-2 and DAP12. J Immunol 177:2051-2055.
30. Hickey WF, Kimura H (1988) Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science 239:290-292.
31. Hsieh CL, Koike M, Spusta SC, Niemi EC, Yenari M, Nakamura MC, Seaman WE (2009) A role for TREM2 ligands in the phagocytosis of apoptotic neuronal cells by microglia. J Neurochem 109:1144-1156.
32. Jones KJ, Serpe CJ, Byram SC, Deboy CA, Sanders VM (2005) Role of the immune system in the maintenance of mouse facial motoneuron viability after nerve injury. Brain Behav Immun 19:12-19.
33. Kiialainen A, Veckman V, Saharinen J, Paloneva J, Gentile M, Hakola P, Hemelsoet D, Ridha B, Kopra O, Julkunen I, Peltonen L (2007) Transcript profiles of dendritic cells of PLOSL patients link demyelinating CNS disorders with abnormalities in pathways of actin bundling and immune response. J Mol Med 85:971-983.
34. Klesney-Tait J, Turnbull IR, Colonna M (2006) The TREM receptor family and signal integration. Nat Immunol 7:1266-1273.
35. Klünemann HH, Ridha BH, Magy L, Wherrett JR, Hemelsoet DM, Keen RW, De Bleecker JL, Rossor MN, Marienhagen J, Klein HE, Peltonen L, Paloneva J (2005) The genetic causes of basal ganglia calcification, dementia, and bone cysts: DAP12 and TREM2. Neurology 64:1502-1507.
36. Koning N, Uitdehaag BMJ, Huitinga I, Hoek RM (2009) Restoring immune suppression in the multiple sclerosis brain. Prog Neurobiol 89:359-368.
37. Korotzer AR, Watt J, Cribbs D, Tenner AJ, Burdick D, Glabe C, Cotman CW (1995) Cultured rat microglia express C1q and receptor for C1q: implications for amyloid effects on microglia. Exp Neurol 134:214-221.
38. Lemere CA, Maier M, Jiang L, Peng Y, Seabrook TJ (2006) Amyloid-b immunotherapy for the prevention and treatment of Alzheimer disease: lessons from mice, monkeys, and humans. Rejuvenation Res 9:77-84.
39. Louvet C, Chiffoleau E, Heslan M, Tesson L, Heslan JM, Brion R, Bériou G, Guillonneau C, Khalife J, Anegon I, Cuturi MC (2005) Identification of a new member of the CD20/FceRIb family overexpressed in tolerated allografts. Am J Transplant 5:2143-2153.
40. Lue LF, Walker DG, Rogers J (2001) Modeling microglial activation in Alzheimer's disease with human postmortem microglial cultures. Neurobiol Aging 22:945-956.
41. Maeda Y, Fujimura L, O-Wang J, Hatano M, Sakamoto A, Arima M, Ebara M, Ino H, Yamashita T, Saisho H, Tokuhisa T (2006) Role of Clast1 in development of cerebellar granule cells. Brain Res 1104:18-26.
42. Melchior B, Puntambekar SS, Carson MJ (2006) Microglia and the control of autoreactive T cell responses. Neurochem Int 49:145-153.
43. Monsonego A, Weiner HL (2003) Immunotherapeutic approaches to Alzheimer's disease. Science 302:834-838.
44. Montalbetti L, Ratti MT, Greco B, Aprile C, Moglia A, Soragna D (2005) Neuropsychological tests and functional nuclear neuroimaging provide evidence of subclinical impairment in Nasu-Hakola disease heterozy-gotes. Funct Neurol 20:71-75.
45. Mott RT, Ait-Ghezala G, Town T, Mori T, Vendrame M, Zeng J, Ehrhart J, Mullan, M, Tan J (2004) Neuronal expression of CD22: novel mechanism for inhibiting microglial proinflammatory cytokine production. Glia 46:369-379.
46. N'Diaye EN, Branda CS, Branda SS, Nevarez L, Colonna M, Lowell C, Hamerman JA, Seaman WE (2009) TREM-2 (triggering receptor expressed on myeloid cells 2) is a phagocytic receptor for bacteria. J Cell Biol 184:215-223.
47. Neumann H, Takahashi K (2007) Essential role of the microglial triggering receptor expressed on myeloid cells-2 (TREM2) for central nervous tissue immune homeostasis. J Neuroimmunol 184:92-99.
48. Piccio L, Buonsanti C, Mariani M, Cella M, Gilfillan S, Cross AH, Colonna M, Panina-Bordignon P (2007) Blockade of TREM-2 exacerbates experimental autoimmune encephalomyelitis. Eur J Immunol 37:1290-1301.
49. Piccio L, Buonsanti C, Cella M, Tassi I, Schmidt RE, Fenoglio C, Rinker II J, Naismith RT, Panina-Bordignon P, Passini N, Galimberti D, Scarpini E, Colonna M, Cross AH (2008) Identification of soluble TREM-2 in the cerebrospinal fluid and its association with multiple sclerosis and CNS inflammation. Brain 131:3081-3091.
50. Pisalyaput K, Tenner AJ (2008) Complement component C1q inhibits beta-amyloid- and serum amyloid P-induced neurotoxicity via caspase- and calpain-independent mechanisms. J Neurochem 104:696-707.
51. Ploix C, Lo D, Carson MJ (2001) A ligand for the chemokine receptor CCR7 can influence the homeostatic proliferation of CD4 T cells and progression of autoimmunity. J Immunol 167:6724-6730.
52. Reichwald J, Danner S, Wiederhold KH, Staufenbiel M (2009) Expression of complement system components during aging and amyloid deposition in APP transgenic mice. J Neuroinflamm 6(35): doi:10.1186/1742-2094-6-35.
53. Schmid CD, Sautkulis LN, Danielson PE, Cooper J, Hasel KW, Hilbush BS, Sutcliffe JG, Carson MJ (2002) Heterogeneous expression of the triggering receptor expressed on myeloid cells-2 on adult murine microglia. J Neurochem 83:1309-1320.
54. Schmid CD, Melchior B, Masek K, Puntambekar SS, Danielson PE, Lo DD, Sutcliffe JG, Carson MJ (2009) Differential gene expression in LPS/IFNc activated microglia and macrophages: in vitro versus in vivo. J Neurochem. 109 (suppl. 1):117-125.
55. Schwab C, Klegeris A, McGeer PL (2009) Inflammation in transgenic mouse models of neurodegenerative disorders. Biochim Biophys Acta, doi:10.1016/ j.bbadis.2009.10.013.
56. Seno H, Miyoshi H, Brown SL, Geske MJ, Colonna M, Stappenbeck TS (2009) Efficient colonic mucosal wound repair requires Trem2 signaling. Proc Natl Acad Sci USA 106:256-261.
57. Serpe CJ, Kohm AP, Huppenbauer CB, Sanders VM, Jones KJ (1999) Exacerbation of facial motoneuron loss after facial nerve transection in severe combined immunodeficient (scid) mice. J Neurosci 19:RC7.
58. Skaper SD, Debetto P, Giusti P (2010) The P2X7 purinergic receptor: from physiology to neurological disorders. FASEB J 24:337-345.
59. Stalder AK, Carson MJ, Pagenstecher A, Asensio VC, Kincaid C, Benedict M, Powell HC, Masliah E, Campbell IL (1998) Late-onset chronic inflammatory encephalopathy in immune-competent and severe combined immune-deficient (SCID) mice with astrocyte-targeted expression of tumor necrosis factor. Am J Pathol 153:767-783.
60. Stefano L, Racchetti G, Bianco F, Passini N, Gupta RS, Bordignon P, Meldolesi J (2009) The surface-exposed chaperone, Hsp60, is an agonist of the microglial TREM2 receptor. J Neurochem 110:284-294.
61. Sturchler-Pierrat C, Abramowski D, Duke M, Wiederhold KH, Mistl C, Rothacher S, Ledermann B, Bürki K, Frey P, Paganetti PA, Waridel C, Calhoun ME, Jucker M, Probst A, Staufenbiel M, Sommer B (1997) Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci USA 94:13287-13292.
62. Takahashi K, Rochford CDP, Neumann H (2005) Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2. J Exp Med 201:647-657.
63. Takahashi K, Prinz M, Stagi M, Chechneva O, Neumann H (2007) TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis. PLoS Med 4:e124
64. Thrash JC, Torbett BE, Carson MJ (2009) Developmental regulation of TREM2 and DAP12 expression in the murine CNS: implications for Nasu-Hakola disease. Neurochem Res 34:38-45.
65. Tian L, Rauvala H, Gahmberg CG (2009) Neuronal regulation of immune responses in the central nervous system. Trends Immunol 30:91-99.
66. Toulme E, Garcia A, Samways D, Egan TM, Carson MJ, Khakh BS (2010) P2X4 receptors in activated C8-B4 cells of cerebellar microglial origin. J Gen Physiol 135:333-353.
67. Turnbull IR, Gilfillan S, Cella M, Aoshi T, Miller M, Piccio L, Hernandez M, Colonna M (2006) TREM-2 attenuates macrophage activation. J Immunol 177:3520-3524.
68. Webster SD, Galvan MD, Ferran E, Garzon-Rodriguez W, Glabe CG, Tenner AJ (2001) Antibody-mediated phagocytosis of the amyloid b-peptide in microglia is differentially modulated by C1q. J Immunol 166:7496-7503.
69. Wilcock DM, Colton CA (2009) Immunotherapy, vascular pathology, and microhemorrhages in transgenic mice. CNS Neurol Disord Drug Targets 8:50-64.
70. Yong VW, Rivest S (2009) Taking advantage of the systemic immune system to cure brain diseases. Neuron 64:55-60.
71. Ziv Y, Ron N, Butovsky O, Landa G, Sudai E, Greenberg N, Cohen H, Kipnis J, Schwartz M (2006) Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood. Nat Neurosci 9:268-275.